Skip to main content
DAEWOONG PHARMA logo

DAEWOONG PHARMA — Investor Relations & Filings

Ticker · 069620 ISIN · KR7069620003 KO Manufacturing
Open in API
Filings indexed 381 across all filing types
Latest filing 2023-10-06 Major Shareholding Noti…
Country KR South Korea
Listing KO 069620

About DAEWOONG PHARMA

http://crm.daewoong.co.kr/eng/main

Daewoong Pharma is an R&D-centric pharmaceutical company specializing in the development, manufacturing, and commercialization of medical products. The company's portfolio encompasses prescription drugs, with a focus on gastrointestinal and endocrine therapies, alongside biologics, healthcare products, and active pharmaceutical ingredients (APIs). A core tenet of its business model is 'Open Collaboration,' actively seeking partnerships with academic and industry entities to foster innovation. Daewoong Pharma's research efforts are directed towards breakthrough therapies, utilizing advanced drug delivery technologies and expertise in biologics. The company also offers integrated formulation and manufacturing services, supporting partners from initial development to commercial production.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Daewoong Pharmaceutical. It details specific transactions (purchases) made by the major shareholder, Daewoong Co., Ltd., and updates the total shareholding percentage. This type of filing is a standard regulatory disclosure regarding significant share ownership changes by insiders or major shareholders, which falls under the 'Major Shareholding Notification' category.
2023-10-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details changes in share ownership by a major shareholder (Daewoong Co., Ltd.) in Daewoong Pharmaceutical. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) or 'Major Shareholding Notification' (MRQ) depending on the context. Given the focus on a major shareholder's change in ownership (10% or more shareholder) and the specific reporting of share transactions, it aligns best with the 'Major Shareholding Notification' category.
2023-10-06 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the National Pension Service's change in shareholding percentage in Daewoong Pharmaceutical. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2023-10-05 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Daewoong Pharmaceutical. It details specific transactions (market purchases) by the major shareholder, Daewoong Co., Ltd., and lists the updated shareholding status of major shareholders and executives. This falls under the category of Major Shareholding Notification (MRQ), as it reports changes in significant share ownership levels.
2023-09-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details changes in share ownership by a major shareholder (Daewoong Co., Ltd.) in Daewoong Pharmaceutical. This type of filing is a standard regulatory disclosure for insider/major shareholder transactions, which falls under the 'Director's Dealing' (DIRS) category in the provided schema.
2023-09-22 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Daewoong Pharmaceutical. It details specific transactions (purchases) made by the major shareholder, Daewoong Co., Ltd., and lists the updated shareholding status of major shareholders and executives. This falls under the category of 'Major Shareholding Notification' (MRQ) as it reports changes in significant share ownership levels.
2023-09-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.